Stephens Inc’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.2M Sell
232,608
-52,296
-18% -$4.22M 0.2% 115
2026
Q1
$24.8M Buy
284,904
+17,286
+6% +$1.66M 0.31% 72
2025
Q4
$25.8M Sell
267,618
-2,143
-0.8% -$208K 0.32% 71
2025
Q3
$25.7M Buy
269,761
+9,000
+3% +$827K 0.33% 71
2025
Q2
$22.7M Sell
260,761
-24,624
-9% -$2.09M 0.31% 81
2025
Q1
$25.6M Buy
285,385
+115,475
+68% +$10.3M 0.38% 65
2024
Q4
$13.6M Sell
169,910
-27,239
-14% -$2.36M 0.19% 120
2024
Q3
$17.7M Buy
197,149
+1,947
+1% +$164K 0.25% 100
2024
Q2
$15.4M Buy
195,202
+19,499
+11% +$1.6M 0.23% 104
2024
Q1
$15.3M Sell
175,703
-3,495
-2% -$298K 0.24% 103
2023
Q4
$14.8M Sell
179,198
-21,531
-11% -$1.64M 0.25% 93
2023
Q3
$15.7M Buy
200,729
+9,009
+5% +$754K 0.3% 80
2023
Q2
$16.9M Sell
191,720
-315
-0.2% -$27.1K 0.3% 80
2023
Q1
$15.5M Sell
192,035
-22,347
-10% -$1.82M 0.3% 82
2022
Q4
$16.7M Sell
214,382
-3,045
-1% -$247K 0.34% 73
2022
Q3
$17.6M Buy
217,427
+3,397
+2% +$305K 0.37% 66
2022
Q2
$19.2M Sell
214,030
-8,587
-4% -$870K 0.39% 61
2022
Q1
$24.7M Buy
222,617
+40,074
+22% +$4.23M 0.4% 55
2021
Q4
$18.9M Sell
182,543
-43,607
-19% -$5.05M 0.29% 82
2021
Q3
$28.3M Buy
226,150
+6,496
+3% +$841K 0.44% 51
2021
Q2
$27.3M Buy
219,654
+19,871
+10% +$2.49M 0.41% 59
2021
Q1
$23.6M Buy
199,783
+12,123
+6% +$1.42M 0.39% 64
2020
Q4
$22M Buy
187,660
+7,432
+4% +$818K 0.39% 56
2020
Q3
$18.7M Buy
180,228
+3,906
+2% +$392K 0.37% 63
2020
Q2
$16.2M Sell
176,322
-7,731
-4% -$741K 0.35% 64
2020
Q1
$16.6M Buy
184,053
+18,004
+11% +$1.92M 0.44% 48
2019
Q4
$18.8M Sell
166,049
-3,852
-2% -$423K 0.39% 57
2019
Q3
$18.5M Sell
169,901
-14,416
-8% -$1.5M 0.41% 60
2019
Q2
$18M Buy
184,317
+14,235
+8% +$1.3M 0.41% 56
2019
Q1
$15.5M Buy
170,082
+18,643
+12% +$1.67M 0.37% 65
2018
Q4
$13.8M Sell
151,439
-5,760
-4% -$538K 0.39% 60
2018
Q3
$15.5M Buy
157,199
+38,844
+33% +$3.59M 0.38% 54
2018
Q2
$10.1M Sell
118,355
-1,135
-0.9% -$94.8K 0.31% 74
2018
Q1
$9.59M Buy
119,490
+9,044
+8% +$746K 0.36% 64
2017
Q4
$8.92M Buy
110,446
+12,921
+13% +$1.03M 0.33% 66
2017
Q3
$7.58M Buy
+97,525
New +$8.1M 0.27% 77
2015
Q1
Sell
-58,726
Closed -$4.24M 844
2014
Q4
$4.24M Buy
58,726
+2,754
+5% +$191K 0.2% 116
2014
Q3
$3.47M Buy
55,972
+28,525
+104% +$1.81M 0.17% 151
2014
Q2
$1.75M Buy
27,447
+1,398
+5% +$84.9K 0.09% 235
2014
Q1
$1.6M Sell
26,049
-930
-3% -$54.2K 0.09% 247
2013
Q4
$1.55M Sell
26,979
-1,335
-5% -$75.7K 0.08% 255
2013
Q3
$1.51M Sell
28,314
-409
-1% -$22K 0.08% 244
2013
Q2
$1.48M Buy
+28,723
New +$1.42M 0.08% 217

Other funds holding MDT

Stephens Inc's MDT Position: Q2 2026 in Review

Stephens Inc reduced its Medtronic (MDT) stake by 18% in Q2 2026, selling an estimated $4.22M and leaving 232,608 shares worth $18.2M. The position accounts for 0.2% of the portfolio, ranked #115.

Stephens Inc first reported a position in MDT in Q2 2013 and has held it in 43 quarters since. The position peaked at $28.3M in Q3 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Stephens Inc held 232,608 shares of Medtronic worth $18.2M as of Q2 2026.
  • Stephens Inc sold 52,296 Medtronic shares in Q2 2026, an estimated $4.22M.
  • Medtronic made up 0.2% of Stephens Inc's portfolio in Q2 2026, its #115 holding.
  • Stephens Inc first reported a position in Medtronic in Q2 2013 and has held it in 43 quarters since.
  • Stephens Inc's Medtronic position peaked at $28.3M in Q3 2021.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Stephens Inc's 13F filing for Q2 2026, filed 29 Jul 2026.